Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc. | 15 | 9 | 1 | 2 | €30.40 | €41.51 | 36.554% |
| Pfizer Inc. | 30 | 4 | 3 | 0 | €26.31 | €40.66 | 54.540% |
| TG Therapeutics Inc. | 22 | 4 | 0 | 0 | €16.62 | €28.06 | 68.900% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.65 | - | - |
| Vertex Pharmaceuticals Inc. | 50 | 2 | 5 | 0 | €444.60 | €429.29 | -3.443% |
| Incyte Corp. | 12 | 2 | 0 | 0 | €59.62 | €78.05 | 30.907% |
| Phibro Animal Health Corp. A | 3 | 2 | 0 | 0 | €16.40 | €12.06 | -26.439% |
| Novavax Inc. | 5 | 2 | 0 | 1 | €13.14 | €17.59 | 33.841% |
| Codexis Inc. | 7 | 2 | 2 | 0 | €2.76 | €8.36 | 202.725% |
| Arrowhead Pharmaceuticals Inc. | 18 | 2 | 4 | 0 | €23.69 | €54.74 | 131.085% |
| Regeneron Pharmaceuticals Inc. | 41 | 1 | 5 | 0 | €992.80 | €1,025.4 | 3.279% |
| Merck & Co. Inc. | 32 | 1 | 4 | 0 | €123.60 | €125.34 | 1.406% |
| Johnson & Johnson | 38 | 1 | 6 | 0 | €138.90 | €187.15 | 34.739% |
| Gilead Sciences Inc | 13 | 1 | 2 | 0 | €66.28 | €83.21 | 25.536% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.11 | €3.70 | 233.333% |
| Biogen Inc. | 50 | 1 | 2 | 0 | €211.80 | €293.22 | 38.444% |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | €159.86 | €200.06 | 25.145% |
| Natural Alternat. | 19 | 1 | 2 | 0 | €5.75 | - | - |